RIVKIN CENTER FOR OVARIAN CANCER
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$1,970,548
Cash & Equivalents
90%
Investments
7%
Receivables (Non-Related)
3%
Prepaid Expenses
<1%
Related-Party Receivables
0%
Inventories
0%
Property, Plant, & Equipment (net)
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$30,329
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,792,874
$1,770,189
-1%
Receivables (Non-Related)
-
$50,000
-
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$18,385
$4,609
-75%
Investments
$138,565
$145,750
+5%
Property, Plant, & Equipment (net)
-
-
-
Other Assets
-
-
-
Total Assets
$1,949,824
$1,970,548
+1%
Liabilities
2023
2024
Change
Payables & Accruals
$31,061
$30,329
-2%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$31,061
$30,329
-2%
Net assets
2023
2024
Change
Restricted Net Assets
$126,888
$390,394
+208%
Unrestricted Net Assets
$1,791,875
$1,549,825
-14%
Net assets
2023
2024
Change
Net assets
+$1,918,763
+$1,940,219
+1%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)